Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
2.61M
-
Shares change
-
+823K
-
Total reported value, excl. options
-
$20.1M
-
Value change
-
+$6.34M
-
Number of buys
-
22
-
Number of sells
-
-16
-
Price
-
$7.72
Significant Holders of GYRE THERAPEUTICS, INC. - COM (GYRE) as of Q1 2025
47 filings reported holding GYRE - GYRE THERAPEUTICS, INC. - COM as of Q1 2025.
GYRE THERAPEUTICS, INC. - COM (GYRE) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.61M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (1.1M shares), BlackRock, Inc. (547K shares), GEODE CAPITAL MANAGEMENT, LLC (312K shares), STATE STREET CORP (129K shares), SBI Securities Co., Ltd. (124K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (111K shares), NORTHERN TRUST CORP (108K shares), UBS Group AG (24.3K shares), AMERICAN CENTURY COMPANIES INC (23.8K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (16.9K shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.